Volume: 2, Issue: 2

ABSTRACT

Antimicrobial resistance (AMR) represents a far-reaching and substantial danger to public health. The emergence of AMR leads to complications in treating infections, contributing to a rise in mortality rates. The broad occurrence of AMR, along with the excessive utilization of antimicrobial drugs, creates a substantial challenge for the restoration of human and animal populations. Urgent attention is required to devise innovative treatments and therapeutics that can effectively address the emergence and spread of resistant strains.